# Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma

> **NCT02743975** · PHASE1,PHASE2 · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 10 (actual)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** Bevacizumab-800CW

## Key facts

- **NCT ID:** NCT02743975
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-01
- **Primary completion:** 2018-02-26
- **Final completion:** 2018-05-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Insufficient tumor-to-background ratios in the first three dose groups
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02743975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02743975, "Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02743975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*